Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-029025
Filing Date
2022-08-11
Accepted
2022-08-11 08:31:34
Documents
63
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q apvo-10q_20220630.htm   iXBRL 10-Q 2140203
2 EX-10.1 apvo-ex101_12.htm EX-10.1 39579
3 EX-10.2 apvo-ex102_13.htm EX-10.2 93281
4 EX-10.3 apvo-ex103_77.htm EX-10.3 15474
5 EX-31.1 apvo-ex311_8.htm EX-31.1 20686
6 EX-31.2 apvo-ex312_7.htm EX-31.2 20768
7 EX-32.1 apvo-ex321_9.htm EX-32.1 10173
8 EX-32.2 apvo-ex322_6.htm EX-32.2 10266
  Complete submission text file 0001564590-22-029025.txt   7538980

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA apvo-20220630.xsd EX-101.SCH 53586
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apvo-20220630_cal.xml EX-101.CAL 37592
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apvo-20220630_def.xml EX-101.DEF 168464
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE apvo-20220630_lab.xml EX-101.LAB 399750
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apvo-20220630_pre.xml EX-101.PRE 297423
57 EXTRACTED XBRL INSTANCE DOCUMENT apvo-10q_20220630_htm.xml XML 1209133
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37746 | Film No.: 221153846
SIC: 2834 Pharmaceutical Preparations